104 related articles for article (PubMed ID: 6177941)
1. Effects of lodoxamide on ischemic reperfused myocardium.
Jolly SR; Abrams GD; Romson JL; Bailie MB; Lucchesi BR
J Cardiovasc Pharmacol; 1982; 4(3):441-8. PubMed ID: 6177941
[TBL] [Abstract][Full Text] [Related]
2. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
Veal CF; Jackson RM; Brannen AL; Fulmer JD
J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
[TBL] [Abstract][Full Text] [Related]
3. Effect of zomepirac on experimental coronary artery thrombosis and ischemic myocardial injury in the conscious dog.
Hook BG; Romson JL; Jolly SR; Bailie MB; Lucchesi BR
J Cardiovasc Pharmacol; 1983; 5(2):302-8. PubMed ID: 6188907
[TBL] [Abstract][Full Text] [Related]
4. Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.
Fiedler VB
Can J Physiol Pharmacol; 1982 Aug; 60(8):1104-11. PubMed ID: 6897011
[TBL] [Abstract][Full Text] [Related]
5. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
Reilly FD; Cilento EV; McCuskey RS
Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
[TBL] [Abstract][Full Text] [Related]
6. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
Parenteau GL; Clark RE
Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
[TBL] [Abstract][Full Text] [Related]
7. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
[TBL] [Abstract][Full Text] [Related]
8. Allopurinol and lodoxamide in complement-induced hepatic ischemia.
Schirmer WJ; Schirmer JM; Naff GB; Fry DE
J Surg Res; 1988 Jul; 45(1):28-36. PubMed ID: 3260642
[TBL] [Abstract][Full Text] [Related]
9. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
McGregor JA; Levin MJ; Masters H
J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
[No Abstract] [Full Text] [Related]
11. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
[TBL] [Abstract][Full Text] [Related]
12. The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.
Fiedler VB
Basic Res Cardiol; 1983; 78(3):266-80. PubMed ID: 6615399
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of nafazatrom on ischemic reperfused myocardium.
Shea MJ; Murtagh JJ; Jolly SR; Abrams GD; Pitt B; Lucchesi BR
Eur J Pharmacol; 1984 Jun; 102(1):63-70. PubMed ID: 6479219
[TBL] [Abstract][Full Text] [Related]
14. Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
Knoop FC; Thomas DD
Infect Immun; 1984 May; 44(2):406-8. PubMed ID: 6143729
[TBL] [Abstract][Full Text] [Related]
15. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
Humphreys RA; Kane KA; Parratt JR
J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
[TBL] [Abstract][Full Text] [Related]
16. Effect of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.
Bush LR; Romson JL; Ash JL; Lucchesi BR
J Cardiovasc Pharmacol; 1982; 4(2):285-96. PubMed ID: 6175813
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of oxidative enzymes by anti-allergy drugs.
White GJ
Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
[TBL] [Abstract][Full Text] [Related]
18. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
[TBL] [Abstract][Full Text] [Related]
19. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
